PACS Group/$PACS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About PACS Group
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.
- Ticker
- $PACS
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 47,455
- Headquarters
- Salt Lake City, United States
- Website
- pacs.com
PACS Group Metrics
BasicAdvanced
$7.6B
27.96
$1.71
-0.08
-
Price and volume
Market cap
$7.6B
Beta
-0.08
52-week high
$50.38
52-week low
$10.31
Average daily volume
804K
Financial strength
Current ratio
0.912
Quick ratio
0.842
Long term debt to equity
2.88
Total debt to equity
3.053
Interest coverage (TTM)
13.88%
Profitability
EBITDA (TTM)
478.3
Gross margin (TTM)
17.32%
Net profit margin (TTM)
4.85%
Operating margin (TTM)
7.39%
Effective tax rate (TTM)
29.67%
Revenue per employee (TTM)
$120,000
Management effectiveness
Return on assets (TTM)
4.60%
Return on equity (TTM)
27.92%
Valuation
Price to earnings (TTM)
27.955
Price to revenue (TTM)
1.353
Price to book
6.82
Price to tangible book (TTM)
7.26
Price to free cash flow (TTM)
16.479
Free cash flow yield (TTM)
6.07%
Free cash flow per share (TTM)
2.901
Growth
Revenue change (TTM)
15.15%
Earnings per share change (TTM)
107.44%
What the Analysts think about PACS Group
Analyst ratings (Buy, Hold, Sell) for PACS Group stock.
Analyst projections of the future price of PACS Group stock.
Bulls say / Bears say
PACS delivered solid underlying growth in Q2: same-store skilled-nursing revenue rose 5.8%, and it lifted its 2026 revenue and adjusted EBITDA guidance. That points to momentum beyond acquisitions. (PACS)
Care quality could help PACS stand out: 83.6% of its skilled-nursing facilities had four- or five-star CMS quality ratings, while mature facilities averaged 4.5 stars. Strong outcomes may support referrals and occupancy. (PACS)
Recent deals give PACS room to expand: it closed on 31 of 34 Eduro facilities and agreed to take over 32 more in Florida. If it integrates them well, the larger footprint could add to future growth. (PACS, Skilled Nursing News)
PACS still faces unresolved government scrutiny of its Medicare billing and referral practices, as well as an SEC investigation into accounting and reporting. Any enforcement action or repayment could hurt earnings and prolong uncertainty. (SEC, Seeking Alpha)
Financial reporting remains a governance risk: PACS said its disclosure controls were ineffective at the end of June, and a federal judge allowed investors’ claim over financial statements in its secondary offering to proceed. That could undermine confidence in reported results and require further remediation. (SEC, Bloomberg Law)
Higher operating costs could absorb some of the gains from better occupancy and reimbursement: wages rose 4% in Q2, while liability insurance added $26.2 million to facility administrative costs. (Seeking Alpha)
Data summarised monthly by Lightyear AI. Last updated on 12 Oct 2026.
PACS Group Financial Performance
Revenues and expenses
PACS Group Earnings Performance
Company profitability
Upcoming events
No upcoming events
PACS Group News
AllArticlesVideos
PACS Group Schedules Third Quarter 2026 Earnings Release and Conference Call
Business Wire4 days ago
Omega to Transition Operations of 32 Facilities in Florida to PACS Group
Business Wire4 weeks ago
Seventeen PACS Post-Acute Locations Named Top Nursing Homes for 2027 by Newsweek Magazine
Business Wire1 month ago
Funds containing PACS Group
AllUSDEURGBP
Fund name | Fund size | $PACS weighting |
|---|---|---|
iShares Ageing Population$AGED | $953M | 0.20% |
iShares Ageing Population€AGED | $903M | 0.20% |
iShares Ageing Population£AGES | $953M | 0.20% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.08% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.08% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.